Nantahala Capital Management’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
CC
ACM
KLC
SAM
DSCM
MAG
BGIM
FWC
Nantahala Capital Management's STIM Position: Q4 2022 in Review
Nantahala Capital Management sold out of Neuronetics (STIM) in Q4 2022, closing a stake of 380,325 shares — an estimated $1.21M sold.
Nantahala Capital Management first reported a position in STIM in Q1 2022 and held it in 3 quarters. The position peaked at $2.67M in Q1 2022. 81 funds tracked by Wall St. Rank hold STIM as of Q4 2022.
- Nantahala Capital Management reported no remaining Neuronetics position as of Q4 2022 after selling out during the quarter.
- Nantahala Capital Management sold 380,325 Neuronetics shares in Q4 2022, an estimated $1.21M.
- Nantahala Capital Management first reported a position in Neuronetics in Q1 2022 and held it in 3 quarters.
- Nantahala Capital Management's Neuronetics position peaked at $2.67M in Q1 2022.
- 81 funds tracked by Wall St. Rank held Neuronetics as of Q4 2022.
Based on Nantahala Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.